Actively Recruiting
Effects of Twice-Daily 7% Hypertonic Saline Nebulization on Lung Mucus Clearance in Adults with Non-Cystic Fibrosis Bronchiectasis
Led by University of North Carolina, Chapel Hill · Updated on 2025-08-13
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of 7% hypertonic saline HS delivered by nebulizer on mucus clearance from the lungs in adults with bronchiectasis that is not caused by cystic fibrosis. The study aims to measure how well the lungs clear inhaled particles before treatment, after a single dose of HS, and after two weeks of twice-daily HS treatment. This open-label, single-arm pilot study focuses on evaluating mucociliary clearance MCC repeatability and the impact of HS on lung function in people with non-CF bronchiectasis. Participants receive 7% HS by nebulizer twice daily for two weeks as part of their airway clearance routine. The study involves up to five visits an initial screening to confirm eligibility and perform a HS tolerance test, one or two baseline visits to assess MCC and lung function, a visit to administer the first HS dose and begin treatment, and a final visit after two weeks of treatment to assess sustained effects. During visits, tests include MCC scans, spirometry, multiple breath washout MBW, sputum collection, and quality of life questionnaires. Throughout the study, medical history and pregnancy status are reviewed. Participants complete lung function tests, MCC assessments, and quality of life surveys at scheduled visits. Researchers measure changes in MCC, lung function FEV1 and lung clearance index, and symptom scores before and after treatment. The study monitors acute and sustained responses to HS, treatment satisfaction, and safety over the treatment period, which may last up to seven weeks depending on visit timing.
CONDITIONS
Brief Title
Hypertonic Saline in NCFB
Research Team
K
Katherine A. Despotes, MD
A
Alex Nesbit
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here